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Background: The incidence of endoprosthesis failure has been well studied, but few studies have described the
clinical characteristics of deep infection in tumor prostheses. This study aimed to analyze the characteristics of deep
infection in tumor endoprostheses around the knee.
Methods: We analyzed clinical data of 57 patients with deep infections involving tumor endoprostheses around
the knee enrolled from the Japanese Musculoskeletal Oncology Group. Profile of clinical presentation including time
between surgery and infection, initial symptoms/blood tests and microbial cultures was evaluated. In addition pre-,
intra-, and postoperative clinical factors influencing clinical presentation and treatment outcomes of infections were
analyzed.
Results: Mean interval between the initial operation and diagnosis was 13 months, and mean time required for
infection control was 12 months. The most common pathogen was Staphylococcus. Infection control rates were
significantly higher when prostheses were removed rather than salvaged. Ten-year prosthesis survival and limb
salvage rates were 41.6% and 75.6%, respectively. Analysis of underlying clinical factors suggested that soft-tissue
condition significantly influenced the duration of the infection control period and likelihood of limb salvage.
Conclusions: Infection control is a prolonged process. Deep infection frequently results in amputation or prosthesis
loss. Intensive analysis of clinical characteristics may aid infection control.
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Massive endoprosthesis implantation is a conventional
and convenient reconstruction modality for limb salvage
operations in patients with malignant bone tumors. The
implantation of these prostheses carries the risk of vari-
ous complications that may require prosthesis removal
or limb amputation. Prosthesis failures are classified as
soft-tissue failures, aseptic loosening, structural failures,
infection, and tumor progression [1]. Besides tumor pro-
gression, deep infection is the most serious of these
complications and the infection rate for patients under-
going endoprosthetic implantation is between 3.6% and* Correspondence: t-morii@gb3.so-net.ne.jp
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reproduction in any medium, provided the or44.6% [1-8]. A large amount of data has been published
detailing the incidence of infection and infection-related
endoprosthesis failure, including prosthesis removal and
amputation. However, few data have been published de-
scribing the clinical properties of infection, including
clinical symptoms at presentation, culture results, treat-
ment modalities, and the underlying factors that might
influence the characteristics of deep infections [2,9].
There are several reasonable explanations for this paucity
of published data. First, the absolute number of deep
infections of tumor endoprosthesis site is small in compari-
son to infections associated with conventional arthroplasty.
For example, Hardes et al. evaluated the clinical results of
30 cases of massive prosthesis infection. Although the
authors intended to examine risk factors for amputation
using multivariate analysis, they concluded that there wasd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Second, there is a wide variety of variables that might affect
infections [8]. Tumor endoprostheses have broader vari-
ation in site, patient age, tumor malignancy, extent of
tumor invasion, need for secure margins, patient immune
condition, defect size, soft-tissue condition, and prosthesis
type than conventional prostheses for total knee or hip
arthroplasty. Finally, variation in the definition of deep in-
fection used by researchers might lead to confusion in
interpreting clinical results or analyzing data published in
the literature [8].
In the present study, we used multiinstitutional retro-
spective surveillance data to analyze the conditions of
tumor endoprosthesis infection around the knee, the
most frequent tumor endoprosthesis infection site [10].
We focused on clinical symptoms, culture results, treat-
ment modalities, the status of prosthesis and limb sal-
vage, and underlying factors that might influence the
characteristics of deep infections.Methods
We analyzed medical records from multiple treatment
centers. Inclusion criteria for this study were: 1) musculo-
skeletal tumor around the knee that was treated at one of
the 29 registered hospitals in the Japanese Musculoskeletal
Oncology Group between 1995 and 2009; 2) use of an
endoprosthesis in reconstruction of the limb; and 3) pa-
tients follow-up for at least 24 months or until patient
death. For primary malignant tumor, wide resection was
performed based on the surgical margin theory [11]. For
metastatic bone tumor, margin was secured in order not
to expose tumor tissue during the operation. In this study,
administration of antibiotics was based on the each insti-
tutional protocol. For all except for one case, postoperative
antibiotics were administrated for more than 3 days. The
definition of deep infection was based on the Centers for
Disease Control and Prevention guidelines [12] with the
following exceptions [8]: organ-specific infection and deep
incisional infection were managed together as “deep infec-
tion” and the detection period for deep infection was not
limited to 12 months from the time of operation. As
described by Hardes et al. [2], infections were considered
controlled when there were no clinical signs of inflamma-
tion and laboratory results indicated normal C-reactive
protein (CRP).
We evaluated the following variables: 1) time between
surgery and infection; 2) initial symptoms/blood tests; 3)
culture results; 4) infection control status; 5) number of
surgical interventions for infection control; 6) modality of
surgical intervention; 7) conservative therapy; 8) prosthesis
survival, and 9) limb salvage. Demographic data and pre-,
intra-, and postoperative factors were analyzed as inde-
pendent variables that might influence characteristics ofinfection (Table 1). We used the definition of Hardes et al.
for bad skin condition [2].
We used Spearman’s rank correlation coefficients,
Mann–Whitney U tests, Fisher’s exact tests, Kaplan Meier
methods and Log-rank tests to evaluate the data, as appro-
priate. Values of P less than 0.05 were considered to denote
significance. Among the above-mentioned independent
variables, only the factors that had significant impact on
the outcomes were presented in the result. Collection of
retrospective clinical data and the publication of the data
were in accordance with local guidelines for research ethics
and were approved by the institutional review board of the
first author (H21-021, 2010/1/5).
Results
Demographic data
A total of 388 cases were evaluated for inclusion in this
study. Of these, 57 (14.6%) were determined to have deep
infections. Histological diagnosis was osteosarcoma (34 cases),
metastatic bone tumor (6 cases), chondrosarcoma (4 cases),
giant cell tumor of bone (3 cases), Ewing’s sarcoma (2 cases), or
others (8 cases). The prostheses used were the Howmedica
Modular Resection SystemW (36 cases), Kyocera Physio Hinge
Total Knee System Type IIIW (13 cases), or others (8 cases).
The oncological outcomes for the infected patients in-
cluded 38 continuous disease free patients, 5 patients
with no evidence of disease, 6 patients who were alive
with disease, 7 patients who were dead of disease, and 1 pa-
tient who died of other disease. Patients were followed for
5- to 213 months (mean, 66 months; median, 60 months).
Other patient demographic data are summarized in
Table 1.
Time between surgery and infection
Infection was diagnosed between 1 and 85 months
(mean, 13 months; median, 4 months) after the initial
surgery (Figure 1). Forty-two cases (73.7%) occurred
within 12 months of surgery. The duration of the sur-
gery–infection interval was significantly associated with
tumor location and intraoperative blood loss. Infection
was detected earlier in tibia cases (mean, 9 months)
than in femur cases (mean, 15 months; P = 0.03). Time
to infection was negatively associated with blood loss
(P = 0.02).
Initial symptoms/blood tests
Because infection was diagnosed based on clinical
symptoms and blood tests, most cases had common
clinical findings of deep infection such as pain, local
heat, discharge/pus, local redness, and elevation of body
temperature [12]. Loosening of the endoprosthesis as an
initial specific symptom of infection was detected in only
5 cases (8.7%). Discharge/pus around the prosthesis was
detected in 32 cases (56.1%). Body temperature at the
Table 1 Pre-, intra-, and postoperative factors of deep
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Table 1 Pre-, intra-, and postoperative factors of deep
infection in tumor endoprostheses (Continued)
Extent of partial resection of the quadriceps muscle (femur cases)
Mean 1.8
Median 2




Bad skin condition 20
Surface infection 9





Discharge/pus at infection presentation 32










Methicillin-resistant S. aureus 10
Staphylococcus epidermidis 10
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(mean, 38.3°C; median, 38.5°C). White blood cell count
(per mm3) ranged from 300 to 18 000 (mean, 9 023; me-
dian, 8 800). In some cases, the white blood cell number
was below normal range due to postoperative chemo-
therapy myelosuppression. CRP levels ranged from 0.2
to 45.1 mg/dL (mean, 11.4 mg/dL; median, 9.0 mg/dL).
Infection occurred significantly earlier in those cases
with discharge/pus than in those without (P = 0.03) and
significantly later in those cases with loosening than in
those without (P = 0.03). Additionally, discharge/pus
was significantly more frequent among cases with extra-
articular resection, than among cases without extra-
articular resection (P = 0.03). Patients with surface
infections had higher CRP values than those who did
not (mean, 21.9 mg/dL vs 9.5 mg/dL; P = 0.009). Body
temperature and white blood cell count were not sig-
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Figure 1 Kaplan-Meier curves showing duration from initial
surgery until infection of each case.
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Pathogens were detected in 43 of the 57 cases examined
(75.4%). The most frequent pathogens detected by culture
included Staphylococcus aureus (S. aureus) (27 cases,
47.4%) and Staphylococcus epidermidis (S. epidermidis)
(10 cases, 17.5%). Among the S. aureus cases, 10 cases
were methicillin-resistant S. aureus (MRSA). Other
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Figure 2 Kaplan-Meier curves showing the duration of the interval be
control (A). Factors that might influence this period include tumor lo
period (D).3 cases of Enterococcus spp. (including polymicrobial
infections), and 2 cases of Pseudomonas aeruginosa. The
pathogens were not defined in 14 cases (24.6%). There
were 2 cases of polymicrobial infection. Both of these
cases were a combination of methicillin-sensitive S. aureus
and Enterococcus spp. S. aureus cases were associated with
extraarticular resection (P = 0.02), extended resection of
the quadriceps muscle in the femur cases (P = 0.003), dis-
charge/pus (P = 0.04), and elevated CRP values (P = 0.04).
MRSA cases were associated with extraarticular resection
(P = 0.02), prolonged operation duration (P = 0.004), and
discharge/pus (P = 0.02). S. epidermidis cases were asso-
ciated with mild inflammatory parameters (body tempe-
rature, P = 0.009; CRP, P = 0.045).
Infection control status
Infections were controlled in 48 cases (84.2%). The pe-
riod between infection diagnosis and infection control
ranged from 1 to 60 months (mean, 12 months; median,
4 months; Figure 2A). Endoprostheses in the tibia were
associated with shorter infection control periods than
in the femur (P = 0.02). Similarly, intracompartmental
tumors were associated with shorter infection control
periods than extracompartmental tumors (P = 0.04). The
surgery-infection interval was negatively associated with
the duration of the control period (cut off, mean pre-
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tween diagnosis of infection and the completion of infection
cation (B), tumor extension (C) and infection presentation
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http://www.biomedcentral.com/1471-2474/14/51patients, infection was considered as uncontrolled based
on the definition of infection control, but did not require
further surgical treatment—at least not until the end of
the study. Of the 9 patients, 4 had fistula with acceptable
general condition in terms of activities of daily life. The
remaining 5 patients showed subtle (sometimes intermit-
tent) clinical symptoms such as local heat or swelling and
elevated CRP levels; these patients required continuous or
intermittent administration of antibiotics despite good
performance status in terms of activities of daily life.Total cases
Number






















Figure 3 Box-and-whisker plots showing the distribution of the numb
Factors significantly influencing the number of surgeries included comorbi
application of gastrocnemius flap (in the tibia cases), and discharge/pus at
modality (B). The modalities in this figure were arranged in order from high
significantly more successful in infection control than those that left the prNumber of surgical interventions for infection control
Patients underwent 0 to 8 surgical interventions for infec-
tion control (mean, 1.84; median, 1; Figure 3A). Patients
with comobidities that increased the risk of infection, such
as diabetes mellitus (P = 0.01); patients of bone metastasis
(P = 0.03); patients who lacked gastrocnemius flap cove-
rage for a prosthesis in the tibia (P = 0.03); and patients
with discharge/pus (P = 0.04), required more surgical in-
terventions for infection control than patients without
these conditions.rimary Yes No
Discharge/PusGastrocnemius flap
Yes No





er of surgical interventions required to control infection (A).
dity as infectious risk, tumor origin (primary versus metastatic),
the initial presentation of infection. Success rate for each surgical
er to lower success rate. Modalities with removal of prostheses were
ostheses in place (right two rows).
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Overall, 91 surgeries were performed and 40 infections
were controlled successfully by surgical intervention. Thus,
the success rate was 44.0% for this intervention strategy.
Surgical modalities and the success rate for each modality
are summarized in Figure 3B. The most successful limb
salvage modality was two-stage revision. Modalities with
prosthesis removal (amputation, rotationplasty, two-stage
revision and arthrodesis) were significantly more successful
than the other treatment modalities examined (P < 0.0001;
Figure 3B, right rows).
Conservative therapy
Among the 48 cases with successful infection control, 8
were controlled with a conservative approach. Conserva-
tive therapy was more successful in cases with prostheses
in the tibia (P = 0.04) and in cases without discharge/pus
at the infection presentation (P = 0.04), than in cases with
other clinical features. Of the 8 patients, 2 developed in-
fection during postoperative chemotherapy. For these
patients, infection was controlled by amelioration of mye-
losuppression. Among the remaining 6 patients, 5 respon-
ded to treatment with a single antibiotic agent within
2 weeks. In the other patient, 40 days were required for

























































Figure 4 Kaplan-Meier survival curves showing prosthesis survival (A)
insertion of endoprostheses. Factors that may significantly influence limb
initial presentation of infection (D).re-evaluation of antibiotic effectiveness according to cul-
ture results; finally, 8 different antibiotics were used for in-
fection control.
Prosthesis survival
In 25 of the 57 cases we examined, the prostheses were
removed. The 5- and 10- year survival rates were 59.3%
and 39.3%, respectively (Figure 4A). Significantly more
prostheses were lost in metastasis cases than in other
cases (P = 0.009).
Limb survival
In 11 of the 57 cases, amputation was performed. Both the
5- and 10-year survival rates were 76.9% (Figure 4B). Risk
of amputation in the course of infection control was
elevated by the case of metastatic bone tumor (P = 0.02);
performance of extraarticular resection during the initial
surgery (P = 0.0003; Figure 4C); use of 1 antibiotic, instead
of 2 antibiotics, during the initial surgery (P = 0.04); and
the presence of discharge/pus at the diagnosis of infection
(P = 0.02; Figure 4D).
Discussion
This study, and several preceding ones, have established






























and limb salvage (B) in patients with deep infections after
survival include extraarticular resection (C) and discharge/pus at the
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rably longer period of follow-up and infection monitoring
for patients with endoprostheses than is required for those
with conventional arthroplasty [2,13,14]; the dominant in-
cidence of staphylococci as the infecting organisms [2,9,15];
the advantages of two-stage revision for infection control
over other limb salvage modalities [2,9,13,14,16,17]; the dif-
ficulty of conservative therapy for deep infection [2,9]; and
the need for more than 2 or more surgical interventions in
order to control an infection [3,9].
Because the diagnosis of infection was based on clinical
findings, we expected some homogeneity of clinical
symptoms among the cases included in our study. How-
ever, we detected some variations in patient condition that
might have influenced their infection condition. Early
infections [2] may be associated with discharge/pus at pre-
sentation, whereas late infections [2] may be associated
with prosthetic loosening. In this study, extraarticular re-
section, resulting in a lack of soft tissue as a protective fac-
tor against infection, was associated with pus/discharge at
presentation and was predictive of poor infection control
period and limb salvage prognoses (Figure 2C and 4C).
This suggests that in cases with extraarticular resection,
both surgeons and patients should recognize the higher
risk for poor treatment outcome. In the present study, in-
fection control rate by soft-tissue flap was 42.9%,
suggesting that soft tissue coverage without prosthesis re-
moval is not sufficient for infection control. Combi-
nation of soft tissue coverage, especially microvascular
free flap coverage, and two-stage revision has been
reported to yield favorable results, highlighting the im-
portance of both soft tissue and prosthesis management
in endoprosthesis infection [18]. We agree that such
methods should be employed, especially in patients at
high risk of poor infection control, such as those with
extraarticular resection or discharge/pus at infection
presentation.
S. aureus infections were associated with a lack of soft
tissue (large defect of quadriceps muscle, extraarticular re-
section). Factors associated with the invasiveness of the
initial operation (extraarticular resection and prolonged
operation time) were especially associated with MRSA in-
fection. In contrast, patients infected with coagulase-
negative staphylococci, displayed considerably milder signs
of infection (low body temperature and CRP) than those
infected with other organisms. This suggests that infection
symptoms might be, at least partly, regulated by the causal
organisms. In the present study, however, negative cul-
tures were considerably more frequent than in previous
studies [2,9]. Pathogens were detected in 75.4% of our
cases, whereas in previous studies, the positive culture
rates were reported to be 89.7% to 93%. In addition, the
incidence of polymicrobial infection was lower in the
present study than in previous studies (3.5% vs 20.7-26%).We also observed a higher incidence of S. aureus- induced
infection in the present study than was reported previously.
In previous reports, coagulase-negative Staphylococcus was
reported to be dominant over S. aureus [2,9]. The factors
underlying such differences are unclear; however, they may
be partially explained by differences in infection location,
soft-tissue condition, antibiotic application, and definition
of infection.
Several factors that may affect infection control status
and numbers of surgical intervention were detected in
the present study. Early amputation after the initial sur-
gery may have been recorded as early infection control
with fewer surgical interventions. Therefore, shorter
control periods or fewer surgical interventions do not
necessarily imply acceptable results for each patient.
Nevertheless, the risk factors that emerged in the
present study for failure of infection control or for more
frequent surgery for infection control, such as tumor
with the extracompartmental extension, comorbidities
that increased the risk of infection, such as diabetes
mellitus, and lack of a gastrocnemius flap in the tibia,
still reinforce the importance of the immune system and
soft-tissue condition in infection control. Unexpectedly,
parameters that represent the intensity of inflammation
such as body temperature or CRP levels did not predict
the treatment outcome of infection. On the other hand,
we emphasized the importance of other clinical key
findings at presentation; discharge or pus at the infection
presentation and the period of infection presentation,
that might be useful for the prediction of treatment out-
come such as the number of surgical intervention or
treatment period for infection control.
The advantage of two-stage revision over other limb sal-
vage modalities has been well established [2,9,13,14,16,17].
Although the success rate of one-stage revision is less than
50% [2,9], this modality can still be used for short-term
infections or patients with extreme comorbidities [19,20].
Debridement without prosthesis removal is not recom-
mended for the control of infection, as it has <5% success
rate [2,9]. Because of the significant difference in the suc-
cess of infection control between prosthesis removal and
prosthesis preservation observed in the present study, we
recommend early removal of prostheses for infection
control.
If the conservative treatment can be successfully com-
pleted, patients can benefit greatly. The difficulty of
conservative therapy is well accepted [2,9], and it was
attempted in less than 10% of the cases we examined.
Our results suggest that conservative therapy may be
attempted in cases without discharge/pus, in limited
circumstances.
Although limb salvage or prosthesis survival rates have
been extensively reported, few data have been published
regarding factors that might influence these rates. The
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limb salvage. Poor skin condition, repeated surgery, radio-
therapy, and lack of soft tissue are factors that may have
affected limb salvage in previous reports [2,21]. In the
present study, we found extraarticular resection and infec-
tion with discharge/pus to be novel risks for amputation,
indicating the significance of soft tissue and early diagnosis
and treatment.
When analyzing the infection of tumor endoprostheses,
one should take into account the rarity of the condition,
the wide variety of independent variables, and the diversity
in the definition of infection. Compared with conventional
arthroplasty, tumor endoprosthesis is less frequent, and
the accompanying independent variables much more di-
verse. In addition, the definition of deep infection might
be different from that in conventional arthroplasty. The
guidelines of the Centers for Disease Control and Pre-
vention [12] define deep infection or organ/space surgi-
cal site infection as infection that occurs within 1 year
of surgery if an implant is in place, appears to be related
to the operation, and involves deep soft tissues. How-
ever, in many previous studies, infections occurring
more than 12 months after initial tumor endoprosthesis
operations were interpreted as surgical site infections
[2,8,9]. In order to overcome these bottlenecks, we
selected a multicenter approach. In addition, we strictly
defined deep infection at the beginning of the study to
avoid confusion in data interpretation.
Nevertheless, the study has some limitations. First, it
lacked a definite protocol for deep infection control,
which resulted in wide variation in treatment modality
among the institutions. The effect of each treatment mo-
dality might not have been precisely evaluated because
its selection depended from the beginning on the in-
fection status. Second, it lacked a definite protocol for
administration of perioperative antibiotics. Third, the
definition of infection used in the present study might
have resulted in the collection of cases with a wide range
of infectious conditions (i.e., from short-term infectious
local findings with good general condition to fatal septic
shocks). In addition, patients who died and thus did not
reach the 24 months of follow-up were included; this
increased the number of infection cases. However, this
might introduce bias because those patients were no
longer subject to the potential risk of infection. Finally,
treatment decision is based on the intention of patients
and surgeons; this might also introduce bias in treat-
ment outcome and prosthesis/limb salvage status. For
example, in this study, patients with metastatic bone
tumor had a higher risk for amputation. This was, at least
partly, due to poorer oncological prognosis, which led
patients or surgeons to select less invasive treatment mo-
dalities. A future prospective study using a well-established
protocol for infection control is necessary.Conclusions
Our study, based on a multiinstitutional survey, provides
an overview of the clinical conditions associated with deep
infection in tumor endoprostheses around the knee. We
examined several factors that likely influence infections,
including infection presentation period, clinical symptoms,
culture results and status of infection control. Prosthesis
removal and preservation of soft tissue are recommended
for infection control.
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